The Acute Myeloid Leukemia (AML) market encompasses the development, production, and distribution of therapeutics and diagnostics aimed at treating and managing AML, a rapidly progressing hematologic malignancy. This market involves chemotherapies, targeted therapies, and emerging immunotherapies, alongside diagnostic tools for early detection and monitoring. It is driven by advanceme... https://www.globalinsightservices.com/reports/acute-myeloid-leukemia-market